FB

Fathima Banna

Active Director Director DIN 08323527
DIN 08323527 First appointment Jan 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2019
Shareholding value •••• Premium profile

About Fathima Banna

Data last updated:

Fathima Banna is a Director at Carencure Pharma Private Limited (since 2019). The company operates in Pharma. Carencure Pharma Private Limited reported revenue of ₹5.46 Cr (FY 2025).

DIN 08323527
Primary Designation Director
Industry Pharma
First Appointment 08 Jan 2019
Oldest Company Age 10 yrs
Largest company Carencure Pharma Private Limited · ₹5.46 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Carencure Pharma Private Limited U85194KL2016PTC046606
Director08 Jan 20192016₹5.46 Cr (FY 2025)Active

Board colleagues of Fathima Banna

Directorship timeline

Open interactive timeline →
Carencure Pharma Private Limited
Premium access

Shareholding and investment profile for Fathima Banna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fathima Banna

Fathima Banna currently holds 1 directorship: Carencure Pharma Private Limited (Director, since 08 Jan 2019, revenue ₹5.46 Cr (FY 2025)).

Fathima Banna was first appointed on 08 Jan 2019 as Director at Carencure Pharma Private Limited.

The current boards of Fathima Banna's companies include Mohammed Abdurahiman Elempilassery Payanad (Carencure Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available